Medicare Covers Genomic Classifier for IPF Diagnosis

  • Research and Development

    Medicare Covers Genomic Classifier for IPF Diagnosis

    Posted by Pulmonary Fibrosis News Moderator on September 11, 2018 at 5:23 pm

    The Envisia Genomic Classifier test for idiopathic pulmonary fibrosis (IPF) diagnosis received a draft Medicare local coverage determination (LCD) through the MolDx (Molecular Diagnostics) service program, according to Veracyte.

    The decision is a key step in making the test widely available to patients, the company says. Read the full story here.

    What do you think about this news?How has Medicare or comparable coverage helped or hindered your diagnosis and treatment?

    replied 6 years ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .